Enkelte mutationer resulterer dog nødvendigvis ikke i klinisk resistens, men multiple mutationer resulterer generelt i klinisk resistens over for mange eller alle aktive substanser inden for klassen.
Single mutations may not result in clinical resistance, but multiple mutations generally result in clinical resistance to many or all active substances within the class.